Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04419389
Brief Title: APR-246 in Combination With Ibrutinib or Venetoclax-R in Subjects With TP53-Mutant R/R Non Hodgkin Lymphomas (NHL) (R/R)

First Submitted : June 1, 2020
First Submitted that Met QC Criteria : June 3, 2020
First Posted : June 5, 2020

Last Update Submitted that Met QC Criteria : January 14, 2021
Last Update Posted : January 19, 2021